Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - NET CHANGE IN CASH
Net Change in Cash TRVI - Trevi Therapeutics, Inc.
19.8 M
LAST VALUE
110.34%
2 YEAR CAGR
27.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR